Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,500.00    -25.00 (-0.45%)
Bid:
5,500.00
Ask:
5,550.00
Spread: 50.00 (0.909%)
Market Cap: £139.03m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

BF&M Strategic Review Conclusion

30 Jan 2023 07:00

RNS Number : 1765O
Camellia PLC
30 January 2023
 

30 January 2023

Camellia Plc

 

(the "Company" or the "Group")

 

Associate Company Update

 

Camellia Plc (CAM.L) notes that its 36.9% owned associate company, BF&M Limited ("BF&M"), a listed Bermudian insurance business, has issued a statement that it has concluded its previously announced strategic review. The BF&M Board has determined that continuing to execute its strategic plan on a standalone basis is in the best interest of all BF&M shareholders, that BF&M remains in a strong capital position, has the right strategic plan already in place and a foundation for growth. BF&M remains focussed on taking decisive steps to create value for its shareholders. The full text of BF&M's announcement can be found in Appendix 1 to this announcement.

 

 

Enquiries

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Susan Walker, Chief Financial Officer

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

 

 

 

  

Appendix 1

BF&M Concludes Strategic Review

 

Hamilton, Bermuda, 7 December 2022 - BF&M Limited ("BF&M", "the BF&M Group" or "the Company") today announced that its Board of Directors (the "Board") concluded its previously announced review of strategic alternatives (the "Strategic Review"). After a comprehensive process with the assistance of Desjardins Capital Markets, the Board has determined that continuing to execute its strategic plan on a standalone basis is in the best interest of all shareholders.

 

Anthony Joaquin, Acting Chairman of the Board, said, "During our review, the Board assessed a comprehensive range of potential outcomes. Ultimately, this process reinforced our confidence that BF&M has the right strategic plan already in place to maximize value for shareholders. With this evaluation concluded, the Board is fully committed to supporting Abigail and the rest of the Company's leadership team as they continue to execute this plan."

 

Abigail Clifford, Chief Executive Officer, said, "BF&M is entering 2023 with a strong capital position and foundation for growth, including the highest AM Best financial strength rating of any domestic insurers operating in Bermuda and the Caribbean. We remain focused on taking decisive steps to create value for shareholders, while providing best-in-class support to our clients as they navigate a challenging economic environment and positioning BF&M as an employer of choice."

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBKLLLXFLFBBF
Date   Source Headline
7th Apr 20152:43 pmRNSAKD Engineering Limited
2nd Apr 20151:44 pmRNSBoard changes
24th Nov 20149:19 amRNSDirectorate Change
2nd Oct 20143:02 pmRNSDirectorate Change
19th Sep 20149:11 amRNSAdmission to AIM
19th Sep 20148:00 amRNSCancellation - Camellia PLC
9th Sep 20142:00 pmRNSUpdate on Move to AIM
2nd Sep 201410:45 amRNSHalf Yearly Report
28th Aug 20147:00 amRNSHalf Yearly Report
20th Aug 20143:15 pmRNSSch 1 - Camellia Plc
20th Aug 20142:40 pmRNSUpdate on Move to AIM
14th Aug 20143:00 pmRNSCancellation of listing on Luxembourg Exchange
6th Aug 20142:30 pmRNSResult of AGM
6th Aug 201411:27 amRNSUpdate on Move to AIM
5th Aug 201410:16 amRNSTrading Update
11th Jul 20143:11 pmRNSShareholder Circular
11th Jul 20147:00 amRNSProposed Move to AIM
13th Jun 201411:16 amRNSNotification of Major Interest In Shares
10th Jun 20142:00 pmRNSDirectorate Change
6th Jun 201411:02 amRNSResult of AGM
5th Jun 201412:30 pmRNSAGM Statement
30th Apr 20142:26 pmRNSReport and Accounts
24th Apr 20144:13 pmRNSFinal Results - Replacement
24th Apr 20147:00 amRNSFinal Results
28th Mar 20143:16 pmRNSInterim Management Statement
3rd Mar 201411:35 amRNSTotal Voting Rights
3rd Feb 201412:32 pmRNSTotal Voting Rights
20th Jan 20144:38 pmRNSTransaction in Own Shares
9th Jan 20147:00 amRNSHolding(s) in Company
9th Jan 20147:00 amRNSTransaction in Own Shares
2nd Jan 20142:42 pmRNSTotal Voting Rights
24th Dec 201311:37 amRNSTransaction in Own Shares
13th Dec 20134:15 pmRNSTransaction in Own Shares
12th Dec 20134:32 pmRNSTransaction in Own Shares
25th Nov 20134:47 pmRNSTransaction in Own Shares
21st Nov 20134:53 pmRNSTransaction in Own Shares
15th Nov 20135:12 pmRNSTransaction in Own Shares
1st Nov 20137:00 amRNSTotal Voting Rights
24th Oct 20137:00 amRNSInterim Management Statement
25th Sep 20133:46 pmRNSShare Transactions
10th Sep 20132:53 pmRNSDirector/PDMR Shareholding
4th Sep 20134:14 pmRNSTransaction in Own Shares
4th Sep 20139:48 amRNSHalf Yearly Report
29th Aug 20137:00 amRNSHalf Yearly Report
1st Jul 20139:57 amRNSTotal Voting Rights
28th Jun 20135:09 pmRNSTransaction in Own Shares
28th Jun 20134:56 pmRNSTransaction in Own Shares
24th Jun 20134:31 pmRNSTransaction in Own Shares
21st Jun 20134:43 pmRNSTransaction in Own Shares
21st Jun 20134:28 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.